Table 2.
Main characteristics of the population (142 patients)
| Age (years) | |
| Mean ± SD | 69.8 ± 10.1 |
| Range | 47–88 |
| Male (n, %) | 93 (65.4%) |
| History of diabetes before hospital admission (n, %) | |
| None | 7 (4.9%) |
| Type 1 diabetes | 3 (2.1%) |
| Type 2 diabetes | 130 (91.6%) |
| Other types | 2 (1.4%) |
| Glucose-lowering drugs (n, %) | |
| None | 12 (8.5%) |
| Oral | 90 (63.4%) |
| Insulin | 35 (24.6%) |
| Insulin and oral drugs | 5 (3.5%) |
| BMI (kg/m2, mean ± SD) | 28.2 ± 4.4 |
| Glycated hemoglobin (%, mean ± SD) | 7.7 ± 1.6 |
| BG (mg/dL, mean ± SD) | |
| At hospital admission | 248.1 ± 99.6 |
| At the end of the insulin infusion | 110.1 ± 20.3 |
| Insulin infusion (median, 25th–75th percentile of median) | |
| Duration (h) | 51 (45–70) |
| Hourly insulin dose at the end of the infusion (units) | 1.5 (1.1–2.2) |
| Subcutaneous insulin (median, 25th–75th percentile of median) | |
| Total daily insulin dose the first day (units) | 36 (24–52) |
| Total daily insulin dose the second day (units) | 40 (26–56) |
| Total daily insulin dose the third day (units) | 40 (26–59) |
| Carbohydrate intake (g/day, mean ± SD) | |
| Glucose intravenous in the last 24 h of insulin infusion | 166.8 ± 9.9 |
| Oral intake of carbohydrates in the first day after transition | 185.6 ± 13.2 |